Researched Medicines Industry (RMI) Code of Practice complaints 2004.
D000329:Advertising / Q000331:legislation & jurisprudence; D001562:Benzimidazoles / Q000627:therapeutic use; D001713:Biphenyl Compounds; D002227:Carbazoles / Q000627:therapeutic use; D000077261:Carvedilol; D032781:Codes of Ethics / Q000331:legislation & jurisprudence*; D034462:Dissent and Disputes / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D019808:Losartan / Q000627:therapeutic use; D009520:New Zealand; D011412:Propanolamines / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use
D001562:Benzimidazoles; D001713:Biphenyl Compounds; D002227:Carbazoles; D011412:Propanolamines; D013777:Tetrazoles; D000077261:Carvedilol; D019808:Losartan; C081643:candesartan